United States: Massachusetts Secretary Sudders Takes Up Price's And Verma's Offer For Medicaid Flexibility

Last Updated: April 20 2017
Article by Thomas Barker

On March 22, 2017, the Massachusetts Secretary of the Executive Office of Health and Human Services (EOHHS) sent a letter to CMS Administrator Seema Verma taking her and HHS Secretary Tom Price up on their offer to grant states more flexibility under the Medicaid program. In her letter, Secretary Sudders pointed to four aspects of the Medicaid program from which Massachusetts would like "immediate relief" and greater flexibility:

  • Flexibility in benefit design;
  • Flexibility in operating the Medicaid prescription drug benefit;
  • Flexibility in the exclusion for treatment services provided in an Institution for Mental Disease (IMD);
  • Flexibility to manage care for dual eligible individuals.

In addition, the letter from Secretary Sudders seeks additional flexibility to enhance the employer-sponsored insurance (ESI) market and the individual insurance market.

We honed right in on Secretary Sudders' comments about Medicaid because we have been predicting for months that the new Administration in Washington would likely offer to work with states in a new partnership to improve the functioning of the Medicaid program. Massachusetts looks like it's ready to dive in.

Let's take a look at some of Secretary Sudders' comments in greater detail and match them up against current Medicaid law:

Flexibility in Benefit Design: Federal law requires that state Medicaid plans make "medical assistance" available to Medicaid enrollees. The term "medical assistance" is quite broad, and as the Massachusetts letter points out, "States should retain the flexibility to design benefit packages that best meet the needs of their enrollees and that more closely align Medicaid coverage with commercial health plans." Although the Sudders letter does not mention it, Congress tried to address this very concern in 2005 by enacting section 1937 of the Social Security Act which grants states greater flexibility to align Medicaid coverage with commercial coverage available in the state, without the need to obtain a waiver from CMS.

The Massachusetts letter points to the decline in ESI in Massachusetts and a corresponding uptick in Medicaid coverage (an issue that Massachusetts Governor Charlie Baker is proposing to address in his state budget proposal for 2018) as the impetus for greater CMS flexibility. At the same time, Secretary Sudders notes that mental health and addiction treatment benefits in commercial plans are not always adequate and that Medicaid may provide greater services in this area. One area where the state suggests flexibility in benefit design is the provision of non-emergency transportation services for the Medicaid expansion population.

Outpatient prescription drugs: As we have noted before, the requirements for coverage of outpatient prescription drugs under section 1927 of the Medicaid program have not seriously been updated since they were first enacted in the early 1990s. Although outpatient drugs are technically an optional benefit, all states cover them. But the requirements for coverage have not reflected the evolution in pharmacy benefit management in the commercial sector.

Secretary Sudders points to this fact in her letter. She says, "we seek greater flexibility to obtain lower drug prices and enhanced rebates for Medicaid, including using the same tools for selecting preferred and covered drugs that are available to and widely used by commercial health plans." (Emphasis added). Ironically, the reason that section 1927 was enacted in the first place was because the Medicaid program had fallen behind the private sector in pharmacy benefit management. Congress may act to address this concern by States this year, but Secretary Sudders sounds like she doesn't want to wait.

We should note that greater state flexibility in this area should set off alarm bells for pharmaceutical manufacturers. The basic "bargain" of section 1927 is that if a manufacturer pays rebates to Medicaid, they are pretty much assured of coverage of their drugs with very few restrictions. It seems clear that states want to drive a harder bargain.

The IMD Exclusion: The IMD exclusion – which excludes from the definition of "medical assistance" most medical services to individuals between the ages of 21 and 65 who are patients in an institution for mental disease (IMD) – is a vestige of the original Medicaid program going back to its enactment in 1965. CMS has tried, over the years (most recently in the May, 2016 Medicaid managed care rule) to demonstrate some flexibility in ameliorating the harsh effects of the exclusion, but the overall restriction remains.

In her letter, Secretary Sudders notes that the IMD exclusion hinders the ability of state Medicaid programs to find solutions to the opioid addiction epidemic. She also suggests that CMS did not go far enough in its recent liberalization of the exclusion in the May, 2016 Medicaid managed care rule. Interestingly, Massachusetts has had a waiver of the IMD exclusion in some form since at least the mid-1990s. The state seems to be requesting even further relief.

Dual-Eligible Enrollees: Massachusetts has, since the 1990s, been in the forefront of innovative medical solutions for individuals who are dually entitled to Medicare and Medicaid. Shortly after the enactment of the Medicare Modernization Act in 2003, Massachusetts began to operate a fully-integrated dual special needs plan (D-SNP) that combines Medicare Parts A, B and D with Medicaid covered health and long-term services and supports. In the letter, the state seeks to expand these services by also managing the Medicare portion of funding for dual-eligible individuals. The letter explains that CMS would "provide the Medicare premium as a capitation payment to the state, and the state would be accountable for managing costs for dual-eligible enrollees within the combined Medicare and Medicaid resources."

This proposal, if adopted, may cause some alarm to hospitals and institutional providers. By controlling the Medicare portion of the capitated payment, the state would likely manage beneficiary care more tightly than happens now in the fee-for-service Medicare program.

The Massachusetts letter to CMS does reinforce our view that the Trump Administration is going to be willing to enter into a new partnership with states to grant greater flexibility in the operation of Medicaid – even in the absence of federal legislation. We expect that the Administration will respond favorably to Secretary Sudders – even though the details may take a while to be worked out. It's worth watching developments in this area. Stakeholders – especially pharmaceutical manufacturers, hospitals and institutional providers – will have a vested interest in the outcome.

To view Foley Hoag's Medicaid and the Law blog please click here

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Events from this Firm
19 Nov 2019, Panel, Massachusetts, United States

Don’t be blindsided by risks you didn’t see coming!

Improve your awareness and understanding of your company’s key risk exposures, and learn how to mitigate and insure them:

19 Nov 2019, Webinar, Boston, United States

This program will feature a practical discussion of how to navigate the new PFMLA and the ongoing changes in guidance on the law, as well as what its implementation could suggest about upcoming changes in employment law on the state and federal level.

13 Dec 2019, Roundtable, Boston, United States

The New England Electricity Restructuring Roundtable has been meeting bimonthly since 1995 to discuss current topics related to important changes in the electric power industry in Massachusetts and throughout New England.

Similar Articles
Relevancy Powered by MondaqAI
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions